left-caret

NEWS

Paul Hastings Represents Sciele Pharma in its Acquisition by Shionogi

September 02, 2008

Atlanta, GA (September 2, 2008) Paul, Hastings, Janofsky & Walker LLP, a leading international law firm, announced today that it represented Sciele Pharma, Inc., a U.S.-based pharmaceutical company, in its agreement to be acquired by Japanese pharmaceutical manufacturer Shionogi & Co., Ltd.

Under the terms of the merger agreement, Shionogi will acquire all the outstanding shares of Scieles common stock at a price of $31 per share, for a total equity purchase price of approximately $1.1 billion and total purchase price of approximately $1.4 billion.

Atlanta partner Tinley Anderson led the Paul Hastings team, which included associates Michael Greene and Clare Arguedas.

About Sciele Pharma: Sciele Pharma, Inc., is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular, Diabetes, Women's Health and Pediatrics. Founded in 1992 and headquartered in Atlanta, Georgia, Sciele Pharma employs more than 900 people.

Paul, Hastings, Janofsky & Walker LLP, founded in 1951, is a leading international law firm with over 1,200 attorneys in 18 offices. The firm serves a diverse client base including many of the leading global financial institutions and Fortune 500 companies and offers deep capabilities in capital markets, finance and restructuring, intellectual property, international arbitration and dispute resolution, investment management, labor and employment, mergers and acquisitions, private equity, product liability, project finance, real estate, securities litigation and tax advisory services. For additional information, please visit our website at www.paulhastings.com.

Practice Areas

Mergers and Acquisitions


SIGN UP FOR NEWS INSIGHTS

MEDIA CONTACTS

M&A, Private Equity, Data Privacy and Cybersecurity, Investment Funds and Private Capital, Structured Credit, Life Sciences, Employment Law and Media and Entertainment

Natalie Gewargis

Antitrust and Competition, Global Finance, Litigation, Financial Restructuring, Intellectual Property, Fintech and Payments, Consumer Financial Services, International Arbitration, and Investigations and White Collar Defense

Becca Hatton

Europe

Miranda Ward

Paris

Katy Foster

Firmwide Inquiries

Elliott Frieder